Avesthagen to Use Affymetrix Microarrays in Parsi Study | GenomeWeb
NEW YORK (GenomeWeb News) – Affymetrix said today that Avesthagen will use its microarrays in a genetic study of the Parsi-Zoroastrian population.
Bangalore, India-based Avesthagen plans to conduct a study, called the AvestaGenome Project, of more than 60,000 Parsi individuals in an effort to reveal the genetic basis of longevity among that population. According to the companies, 31 percent of the Parsi population lives beyond the age of 60 compared to 7 percent nationally in India.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.